1. Home
  2. GRNT vs EMBC Comparison

GRNT vs EMBC Comparison

Compare GRNT & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Ridge Resources Inc.

GRNT

Granite Ridge Resources Inc.

HOLD

Current Price

$5.11

Market Cap

662.8M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$9.78

Market Cap

602.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRNT
EMBC
Founded
2013
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
662.8M
602.3M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
GRNT
EMBC
Price
$5.11
$9.78
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$8.00
$18.50
AVG Volume (30 Days)
550.0K
906.8K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
8.54%
6.18%
EPS Growth
N/A
20.90
EPS
0.38
0.74
Revenue
$380,030,000.00
N/A
Revenue This Year
$34.25
$1.17
Revenue Next Year
$9.17
N/A
P/E Ratio
$13.51
$13.18
Revenue Growth
N/A
N/A
52 Week Low
$4.18
$9.20
52 Week High
$6.59
$15.55

Technical Indicators

Market Signals
Indicator
GRNT
EMBC
Relative Strength Index (RSI) 56.33 35.25
Support Level $4.84 $9.45
Resistance Level $5.43 $10.88
Average True Range (ATR) 0.18 0.35
MACD -0.01 0.01
Stochastic Oscillator 55.34 12.98

Price Performance

Historical Comparison
GRNT
EMBC

About GRNT Granite Ridge Resources Inc.

Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: